Safety, Tolerability and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV Infected Patients Receiving Combination Antiretroviral Therapy. Results of the ACTG 5176 Trial

BACKGROUND: HIV-specific cellular immune responses are associated with control of viremia and delayed disease progression. An effective therapeutic vaccine could mimic these effects and reduce the need for continued antiretroviral therapy. DermaVir, a topically administered pDNA-nanomedicine express...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rodriguez, Benigno, Asmuth, David M., Matining, Roy M., Spritzler, John, Jacobson, Jeffrey, Mailliard, Robbie, Li, Xiao-Dong, Martinez, Ana I., Tenorio, Allan, Lori, Franco, Lisziewicz, Julianna, Yesmin, Suria, Rinaldo, Charles R., Pollard, Richard B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3858388/
https://ncbi.nlm.nih.gov/pubmed/24169120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3182a99590
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados